Bristol-Myers Squibb Company (BMY)

73.80
+1.68(+2.33%)
After Hours
73.87
+0.07(+0.09%)
- Real-time Data
  • Volume:
    9,692,298
  • Day's Range:
    71.90 - 73.83
  • 52 wk Range:
    53.22 - 80.59

BMY Overview

Prev. Close
72.12
Day's Range
71.9-73.83
Revenue
47.14B
Open
72.07
52 wk Range
53.22-80.59
EPS
3.04
Volume
9,692,298
Market Cap
157.58B
Dividend (Yield)
2.16
(2.93%)
Average Volume (3m)
12,192,094
P/E Ratio
23.87
Beta
0.394
1-Year Change
5.87%
Shares Outstanding
2,135,255,158
Next Earnings Date
25 Oct 2022
What is your sentiment on Bristol-Myers Squibb?
or
Market is currently closed. Voting is open during market hours.

Bristol-Myers Squibb Company Analysis

Bristol-Myers Squibb Company Company Profile

Bristol-Myers Squibb Company Company Profile

Employees
30250

Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. The Company’s pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company’s products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuyBuy
Technical IndicatorsBuyStrong BuyStrong BuySellStrong Buy
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Buy